Markets
U.S. open in 22 hrs, 27 mins
BUSINESS NEWS
- Market News
- Earnings
- Recalls
- Recession Watch
- Tech News
- Financial Crisis
- Madoff Scandal
- BloggingStocks
- Luxist
- Money Videos
INVESTING
- Stock Quotes
- Stock Charts
- Stock Ticker
- Currencies
- Portfolio
- Stock Screener
- Broker Center
- Mutual Fund Center
- ETF Center
- Money
- 24/7 Wall St.
- Financial Glossary
PERSONAL FINANCE AT WALLETPOP
- Bargains
- Banking
- Budget
- Calculators
- College Finance
- Community
- Credit
- Deals
- Debt
- Economizer
- Food
- Home
- Fraud
- Insurance
- Interest Rates
- Loans
- Mortgages
- Real Estate
- Recalls
- Recession
- Retirement
- Saving
- Simplification
- Specials
- Taxes
SMALL BUSINESS
New Patent Issued to ImmuDyne by the U.S. Patent Office
GlobeNewswire
posted: 152 DAYS AGO
FLORENCE, Ky., June 30, 2009 (GLOBE NEWSWIRE) -- ImmuDyne (Pink Sheets:IMMD), continuing to build its intellectual property and leadership role in Beta Glucan technology, today announced that the Company recently received an issue notice from the U.S. Patent Office. ImmuDyne's patent application entitled, Methods of Purifying Beta Glucans (Amended), has now been issued as U.S. Patent 7,750,584.
ImmuDyne shares trade under the ticker symbol IMMD (PK) and the Company can be found on the web at www.immudyne.com
CONTACT: ImmuDyne, Inc.
Investors:
Mark McLaughlin
1-914-714-8901
sales@immudyne.com